EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Defining Optimal Immunotherapies For Type 1 Diabetes Novartis Foundation Symposium 292 1st Edition Novartis Foundation

Name: Defining Optimal Immunotherapies For Type 1 Diabetes Novartis Foundation Symposium 292 1st Edition Novartis Foundation
SKU: BELL-2166538
Price: 31.00 USD
Availability: InStock
Rating: 5 (80 reviews)

SKU: BELL-2166538

$ 31.00 ~~$ 45.00~~ (-31%)

5.0

80 reviews

Defining Optimal Immunotherapies For Type 1 Diabetes Novartis Foundation Symposium 292 1st Edition Novartis Foundation instant download after payment.

Publisher: Wiley

File Extension: PDF

File size: 1.89 MB

Pages: 224

Author: Novartis Foundation

ISBN: 9780470697412, 9780470723258

Language: English

Year: 2008

Edition: 1

Product desciption

Defining Optimal Immunotherapies For Type 1 Diabetes Novartis Foundation Symposium 292 1st Edition Novartis Foundation by Novartis Foundation 9780470697412, 9780470723258 instant download after payment.

This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.The book integrates information from human and animal studies.The book considers T1D within the broader context of autoimmune disease.The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.